Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Primary Care
Published in: BMC Primary Care 1/2013

Open Access 01-12-2013 | Study protocol

Recognition of depression and anxiety and their association with quality of life, hospitalization and mortality in primary care patients with heart failure – study protocol of a longitudinal observation study

Authors: Marion Eisele, Eva Blozik, Stefan Störk, Jens-Martin Träder, Christoph Herrmann-Lingen, Martin Scherer

Published in: BMC Primary Care | Issue 1/2013

Login to get access

Abstract

Background

International disease management guidelines recommend the regular assessment of depression and anxiety in heart failure patients. Currently there is little data on the effect of screening for depression and anxiety on the quality of life and the prognosis of heart failure (HF). We will investigate the association between the recognition of current depression/anxiety by the general practitioner (GP) and the quality of life and the patients’ prognosis.

Methods/Design

In this multicenter, prospective, observational study 3,950 patients with HF are recruited by general practices in Germany. The patients fill out questionnaires at baseline and 12-month follow-up. At baseline the GPs are interviewed regarding the somatic and psychological comorbidities of their patients. During the follow-up assessment, data on hospitalization and mortality are provided by the general practice. Based on baseline data, the patients are allocated into three observation groups: HF patients with depression and/or anxiety recognized by their GP (P+/+), those with depression and/or anxiety not recognized (P+/−) and patients without depression and/or anxiety (P−/−). We will perform multivariate regression models to investigate the influence of the recognition of depression and/or anxiety on quality of life at 12 month follow-up, as well as its influences on the prognosis (hospital admission, mortality).

Discussion

We will display the frequency of GP-acknowledged depression and anxiety and the frequency of installed therapeutic strategies. We will also describe the frequency of depression and anxiety missed by the GP and the resulting treatment gap. Effects of correctly acknowledged and missed depression/anxiety on outcome, also in comparison to the outcome of subjects without depression/anxiety will be addressed. In case results suggest a treatment gap of depression/anxiety in patients with HF, the results of this study will provide methodological advice for the efficient planning of further interventional research.
Appendix
Available only for authorised users
Literature
1.
Hunt SA: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005, 46: e1-e82. 10.1016/j.jacc.2005.08.022.CrossRefPubMed
2.
Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M: Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002, 87: 235-241. 10.1136/heart.87.3.235.CrossRefPubMedPubMedCentral
3.
Masoudi FA, Rumsfeld JS, Havranek EP, House JA, Peterson ED, Krumholz HM, Spertus JA: Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail. 2004, 10: 368-373. 10.1016/j.cardfail.2004.01.009.CrossRefPubMed
4.
Scherer M, Stanske B, Wetzel D, Koschack J, Kochen MM, Herrmann-Lingen C: [Disease-specific quality of life in primary care patients with heart failure]. Z Arztl Fortbild Qualitatssich. 2007, 101: 185-190.PubMed
5.
Pelle AJM, Gidron YY, Szabó BM, Denollet J: Psychological predictors of prognosis in chronic heart failure. J Card Fail. 2008, 14: 341-350. 10.1016/j.cardfail.2008.01.004.CrossRefPubMed
6.
Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ: Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006, 48: 1527-1537.CrossRefPubMed
7.
Parissis JT, Fountoulaki K, Paraskevaidis I, Kremastinos D: Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches. Expert Opin Investig Drugs. 2005, 14: 567-577. 10.1517/13543784.14.5.567.CrossRefPubMed
8.
Faller H, Störk S, Schowalter M, Steinbüchel T, Wollner V, Ertl G, Angermann CE: Depression and survival in chronic heart failure: does gender play a role?. Eur J Heart Fail. 2007, 9: 1018-1023. 10.1016/j.ejheart.2007.06.011.CrossRefPubMed
9.
Faller H, Störk S, Schowalter M, Steinbüchel T, Wollner V, Ertl G, Angermann CE: Is health-related quality of life an independent predictor of survival in patients with chronic heart failure?. J Psychosom Res. 2007, 63: 533-538. 10.1016/j.jpsychores.2007.06.026.CrossRefPubMed
10.
Olafiranye O, Jean-Louis G, Zizi F, Nunes J, Vincent M: Anxiety and cardiovascular risk: review of epidemiological and clinical evidence. Mind Brain. 2011, 2: 32-37.PubMedPubMedCentral
11.
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009, 119: e391-e479.CrossRefPubMed
12.
Heart Failure Society of America: Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010, 16: 475-539. 10.1016/j.cardfail.2010.04.005.CrossRef
13.
14.
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012, 33: 1787-1847.CrossRefPubMed
15.
16.
Moraska AR, Chamberlain AM, Shah ND, Vickers KS, Rummans TA, Dunlay SM, Spertus JA, Weston SA, McNallan SM, Redfield MM, Roger VL: Depression, Healthcare Utilization, and Death in Heart Failure: A Community Study. Heart Fail Circ. 2013, 6: 387-394. 10.1161/CIRCHEARTFAILURE.112.000118.CrossRef
17.
Rollman BL, Herbeck Belnap B, Mazumdar S, Houck PR, He F, Alvarez RJ, Schulberg HC, Reynolds CF, McNamara DM: A positive 2-item patient health questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality. J Card Fail. 2012, 18: 238-245. 10.1016/j.cardfail.2011.11.002.CrossRefPubMed
18.
Angermann CE, Gelbrich G, Störk S, Fallgatter A, Deckert J, Faller H, Ertl G: Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail. 2007, 9: 1212-1222. 10.1016/j.ejheart.2007.10.005.CrossRefPubMed
19.
O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, Stough WG, Arias RM, Rivelli SK, Krishnan R: Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) Trial. J Am Coll Cardiol. 2010, 56: 692-699. 10.1016/j.jacc.2010.03.068.CrossRefPubMedPubMedCentral
20.
Wittchen H, Winter S, Höfler M, Spiegel B, Ormel H, Müller M, Pfister H: Prevalence and recognition rates of generalized anxiety and depression in primary care. Fortschr Med Orig. 2001, 118: 22-30.
21.
Cully JA, Jimenez DE, Ledoux TA, Deswal A: Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry. 2009, 11: 103-109. 10.4088/PCC.08m00700.CrossRefPubMedPubMedCentral
22.
Thombs BD, Roseman M, Coyne JC, de Jonge P, Delisle VC, Arthurs E, Levis B, Ziegelstein RC: Does evidence support the American Heart Association’s recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS One. 2013, 8: e52654-10.1371/journal.pone.0052654.CrossRefPubMedPubMedCentral
23.
Thombs BD: No evidence for depression screening in cardiovascular care settings: a comment on CANMAT task force recommendations. Ann Clin Psychiatry. 2012, 24: 319-320. author reply 320–322PubMed
24.
Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, Zuidersma M, Eze-Nliam C, Lima BB, Smith CG, Soderlund K, Ziegelstein RC: Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA. 2008, 300: 2161-2171. 10.1001/jama.2008.667.CrossRefPubMed
25.
Ziegelstein RC, Thombs BD: Is routine screening a parachute for heart disease patients with depression?. J Psychosom Res. 2011, 71: 3-5. 10.1016/j.jpsychores.2011.03.007.CrossRefPubMed
26.
Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient health questionnaire. JAMA. 1999, 282: 1737-1744. 10.1001/jama.282.18.1737.CrossRefPubMed
27.
Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16: 606-613. 10.1046/j.1525-1497.2001.016009606.x.CrossRefPubMedPubMedCentral
28.
Löwe B, Gräfe K, Zipfel S, Witte S, Loerch B, Herzog W: Diagnosing ICD-10 depressive episodes: superior criterion validity of the patient health questionnaire. Psychother Psychosom. 2004, 73: 386-390. 10.1159/000080393.CrossRefPubMed
29.
Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002, 52: 69-77. 10.1016/S0022-3999(01)00296-3.CrossRefPubMed
30.
Herrmann-Lingen C, Buss U, Snaith R: HADS-D - Hospital Anxiety and Depression Scale - Deutsche Version: Deutsche Adaptation der Hospital Anxiety and Depression Scale (HADS). 2005, Bern: Huber, 2
31.
Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D: Item Banks for Measuring Emotional Distress From the Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, Anxiety, and Anger. Assessment. 2011, 18: 263-283. 10.1177/1073191111411667.CrossRefPubMedPubMedCentral
32.
Choi SW, Reise SP, Pilkonis PA, Hays RD, Cella D: Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res. 2010, 19: 125-136. 10.1007/s11136-009-9560-5.CrossRefPubMed
33.
Spitzer RL, Kroenke K, Williams JBW, Lowe B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006, 166: 1092-1097. 10.1001/archinte.166.10.1092.CrossRefPubMed
34.
Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, Herzberg PY: Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population. Med Care. 2008, 46: 266-274. 10.1097/MLR.0b013e318160d093.CrossRefPubMed
35.
Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007, 146: 317-325. 10.7326/0003-4819-146-5-200703060-00004.CrossRefPubMed
36.
Lubben J, Blozik E, Gillmann G, Iliffe S, Kruse W von R, Beck JC, Stuck AE: Performance of an abbreviated version of the Lubben social network scale among three European community-dwelling older adult populations. Gerontologist. 2006, 46: 503-513. 10.1093/geront/46.4.503.CrossRefPubMed
37.
Cordes A, Herrmann-Lingen C, Büchner B, Hessel A: Repräsentative Normierung des ENRICHD-Social-Support-Instrument (ESSI) – Deutsche Version. Klin Diagnostik u Evaluation. 2009, 2: 16-32. Jg
38.
39.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ: Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008, 10: 348-354. 10.1111/j.1751-7176.2008.07572.x.CrossRef
40.
Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS: Improving the measurement of self-reported medication nonadherence: Response to Authors. J Clin Epidemiol. 2011, 64: 258-261. 10.1016/j.jclinepi.2010.02.023.CrossRef
41.
Morisky DE, DiMatteo MR: Improving the measurement of self-reported medication nonadherence: final response. J Clin Epidemiol. 2011, 64: 262-263. 10.1016/j.jclinepi.2010.09.010.CrossRef
42.
Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J: Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013, 22 (7): 1717-1727. 10.1007/s11136-012-0322-4.CrossRefPubMed
43.
Hinz A, Schumacher J, Albani C, Schmid G, Brähler E: Bevölkerungsrepräsentative Normierung der Skala zur Allgemeinen Selbstwirksamkeitserwartung. Diagnostica. 2006, 52: 26-32. 10.1026/0012-1924.52.1.26.CrossRef
44.
Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kuslansky G, Ambrose AF, Sliwinski M, Buschke H: Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003, 348: 2508-2516. 10.1056/NEJMoa022252.CrossRefPubMed
45.
Jöckel K, Babitsch B, Bellach B, Bloomfield K, Hoffmeyer-Zlotnik J, Winkler J, Wolf C: Messung und Quantifizierung soziographischer Merkmale in epidemiologischen Studien. Messung soziodemographischer Merkmale in der Epidemiologie. 1998, München: MMV Medizin Verlag München
46.
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed
47.
Wittchen H, Zaudig M, Fydrich T: Strukturiertes Klinisches Interview für DSM-IV. 1997, Göttingen: Hogrefe
48.
First M, Spitzer R, Gibbon M, Williams J: Structured Clinical Interview for DSM-IV Axis I Disorders. 1996, New York, NY: Biometrics Research Departement, New Yourk State Psychiatric Institute
49.
De Dios C, Ezquiaga E, García A, Montes JM, Avedillo C, Soler B: Usefulness of the Spanish version of the mood disorder questionnaire for screening bipolar disorder in routine clinical practice in outpatients with major depression. Clin Pract Epidemiol Ment Health. 2008, 4: 14-10.1186/1745-0179-4-14.CrossRefPubMedPubMedCentral
50.
Müller MJ, Szegedi A, Wetzel H, Benkert O: Moderate and severe depression. Gradations for the Montgomery-Asberg depression rating scale. J Affect Disord. 2000, 60: 137-140. 10.1016/S0165-0327(99)00162-7.CrossRefPubMed
Metadata
Title
Recognition of depression and anxiety and their association with quality of life, hospitalization and mortality in primary care patients with heart failure – study protocol of a longitudinal observation study
Authors
Marion Eisele
Eva Blozik
Stefan Störk
Jens-Martin Träder
Christoph Herrmann-Lingen
Martin Scherer
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2013
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/1471-2296-14-180

Other articles of this Issue 1/2013

BMC Primary Care 1/2013 Go to the issue

Research article

How do GPs identify a need for palliative care in their patients? An interview study

Study protocol

An evidence-based shared decision making programme on the prevention of myocardial infarction in type 2 diabetes: protocol of a randomised-controlled trial

Research article

Primary care clinicians’ attitudes towards point-of-care blood testing: a systematic review of qualitative studies

Research article

Patients’ perceptions of depression and coronary heart disease: a qualitative UPBEAT-UK study

Research article

Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study

Research article

Satisfaction of well-controlled type 2 diabetes patients with three-monthly and six-monthly monitoring